HSR20-099: Cost Comparison of PARP Inhibitors in Women With Ovarian Cancer (OC) in the US HealthCare Market

Authors:
Ali McBride University of Arizona Cancer Center, Tucson, AZ

Search for other papers by Ali McBride in
Current site
Google Scholar
PubMed
Close
 PharmD, MS, BCOP
,
Jessica Perhanidis TESARO: A GSK Company, Waltham, MA

Search for other papers by Jessica Perhanidis in
Current site
Google Scholar
PubMed
Close
 MPH
,
Craig Gibson TESARO: A GSK Company, Waltham, MA

Search for other papers by Craig Gibson in
Current site
Google Scholar
PubMed
Close
 PhD
, and
Gene Wetzstein TESARO: A GSK Company, Waltham, MA

Search for other papers by Gene Wetzstein in
Current site
Google Scholar
PubMed
Close
 PharmD, BCOP, CPh
Restricted access

Corresponding Author: Ali McBride, PharmD, MS, BCOP
  • Collapse
  • Expand

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 2265 395 80
PDF Downloads 967 0 0
EPUB Downloads 0 0 0